New 52-week analyses from the phase 3 SOL-1 trial suggest that the investigational intravitreal therapy AXPAXLI (OTX-TKI) may ...
Manufacturing Agreement Advances Metformin Ophthalmology Platform Toward First-in-Human Clinical StudyPalm Beach Gardens, FL, April 15, 2026 ...
Talking With Docs on MSN
Macular degeneration: the leading cause of blindness in the developed world
Macular degeneration: the leading cause of blindness in the developed world ...
5d
Dear Abby: Young people think they don’t have to worry about eye health; they couldn’t be more wrong
Abby, regular eye exams and timely interventions can reduce the risk of severe vision loss by more than 90%. However, only ...
Dear Abby is written by Abigail Van Buren, also known as Jeanne Phillips, and was founded by her mother, Pauline Phillips.
I’m an ophthalmologist, a physician who specializes in medical and surgical eye care, and I’m hoping you can help me debunk a ...
A new study reveals an unexpected mechanism behind how humans develop sharp, color-rich vision before birth, pointing to a coordinated role between key biochemical signals in the retina.
Trends in the rates of glaucoma, cataract and age-related macular degeneration around the world point to a “complex interplay ...
Copyright: © 2026 The Author(s). Published by Elsevier Ltd. Anti-VEGF therapy is the primary treatment for nAMD, a leading cause of blindness among older individuals ...
AMD is a common cause of blindness in high-income countries. It has previously been established that treatment has a high patient and financial burden, with limited long-term success. Prior analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results